Naoki Kojima

1.0k total citations
70 papers, 714 citations indexed

About

Naoki Kojima is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Naoki Kojima has authored 70 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Surgery. Recurrent topics in Naoki Kojima's work include Sarcoma Diagnosis and Treatment (21 papers), Peptidase Inhibition and Analysis (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Naoki Kojima is often cited by papers focused on Sarcoma Diagnosis and Treatment (21 papers), Peptidase Inhibition and Analysis (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Naoki Kojima collaborates with scholars based in Japan, United Kingdom and United States. Naoki Kojima's co-authors include Jan M. Williams, Richard J. Roman, Teisuke Takahashi, Noriyuki Miyata, Junji Konishi, Yoji Maetani, Shigeto Yamada, Yoshiomi Imamura, Hiromi Nabeta and Toshiro Kawashima and has published in prestigious journals such as Radiology, Endocrinology and Hypertension.

In The Last Decade

Naoki Kojima

63 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Kojima Japan 14 220 214 147 136 135 70 714
James X. Wu United States 18 428 1.9× 321 1.5× 73 0.5× 153 1.1× 88 0.7× 75 899
Andy Lee United States 11 138 0.6× 212 1.0× 81 0.6× 138 1.0× 205 1.5× 29 771
Zeyad T. Sahli United States 17 224 1.0× 183 0.9× 43 0.3× 59 0.4× 88 0.7× 28 610
Kristian Vinter Juul Denmark 17 333 1.5× 112 0.5× 305 2.1× 179 1.3× 198 1.5× 46 984
Christoph Reichetzeder Germany 22 87 0.4× 167 0.8× 93 0.6× 114 0.8× 276 2.0× 42 1.1k
Ho‐Cheol Kang South Korea 21 332 1.5× 724 3.4× 98 0.7× 223 1.6× 174 1.3× 129 1.3k
Jiuhong Yuan China 23 330 1.5× 351 1.6× 174 1.2× 95 0.7× 474 3.5× 100 1.6k
Kiwon Kim South Korea 16 163 0.7× 219 1.0× 47 0.3× 39 0.3× 152 1.1× 40 773
Alan O. Malabanan United States 18 151 0.7× 178 0.8× 33 0.2× 77 0.6× 167 1.2× 45 1.0k
Riccardo Pofi Italy 22 352 1.6× 579 2.7× 118 0.8× 58 0.4× 352 2.6× 72 1.4k

Countries citing papers authored by Naoki Kojima

Since Specialization
Citations

This map shows the geographic impact of Naoki Kojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Kojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Kojima more than expected).

Fields of papers citing papers by Naoki Kojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Kojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Kojima. The network helps show where Naoki Kojima may publish in the future.

Co-authorship network of co-authors of Naoki Kojima

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Kojima. A scholar is included among the top collaborators of Naoki Kojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Kojima. Naoki Kojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hikichi, Hirohiko, Jun-ichi Karasawa, Kenichi Fukumoto, et al.. (2025). Preclinical pharmacological profiles of vornorexant, a novel potent dual orexin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics. 392(7). 103624–103624. 2 indexed citations
2.
Kojima, Naoki, et al.. (2024). Discovery of TP0628103: A Highly Potent and Selective MMP-7 Inhibitor with Reduced OATP-Mediated Clearance Designed by Shifting Isoelectric Points. Journal of Medicinal Chemistry. 67(2). 1406–1420. 1 indexed citations
3.
Kojima, Naoki, Tetsuro Taki, Tomohiro Miyoshi, et al.. (2024). Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour. Histopathology. 86(3). 365–372. 5 indexed citations
4.
Noguchi, Rei, Takuya Ono, Taro E. Akiyama, et al.. (2024). Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. Human Cell. 37(3). 874–885. 4 indexed citations
5.
Noguchi, Rei, Takuya Ono, Taro E. Akiyama, et al.. (2024). Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1. Human Cell. 37(6). 1742–1750.
6.
Noguchi, Rei, Takuya Ono, Taro E. Akiyama, et al.. (2024). Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone. Human Cell. 38(1). 29–29. 1 indexed citations
7.
Ono, Takuya, Rei Noguchi, Taro E. Akiyama, et al.. (2024). Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Human Cell. 37(3). 854–864. 1 indexed citations
8.
Kojima, Naoki, et al.. (2023). Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis. Journal of Medicinal Chemistry. 66(21). 14653–14668. 2 indexed citations
9.
Hirata, Takashi, et al.. (2023). Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 386(1). 56–69.
10.
Yoshida, Akihiko, et al.. (2023). Case Report: Painful EWSR1::SMAD3-Positive fibroblastic tumor invading bone. 2(4). 188–191. 1 indexed citations
11.
Kojima, Naoki, Takashi Kubo, Taisuke Mori, et al.. (2023). Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(1). 71–81. 2 indexed citations
12.
Tanaka, Hiroki, Makoto Hamada, Yuji Ito, et al.. (2022). Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition. Journal of Medicinal Chemistry. 65(21). 14599–14613. 5 indexed citations
13.
Mitani, Akiko, et al.. (2022). Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1′ Subsite Binder with Short Peptides. Journal of Medicinal Chemistry. 65(19). 13253–13263. 5 indexed citations
14.
Kojima, Naoki, Yasuhito Arai, Kaishi Satomi, et al.. (2022). Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall. Modern Pathology. 35(10). 1439–1448. 13 indexed citations
15.
Imamura, Takeaki, et al.. (2014). Pheochromocytoma crisis with acute heart failure and multiple organ failure. Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine. 25(7). 313–318.
16.
Matsushima, Jun, Toshiro Kawashima, Hiromi Nabeta, et al.. (2014). Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: A 3-year follow-up study. Journal of Affective Disorders. 173. 9–14. 25 indexed citations
17.
Nabeta, Hiromi, Yoshito Mizoguchi, Jun Matsushima, et al.. (2014). Association of salivary cortisol levels and later depressive state in elderly people living in a rural community: A 3-year follow-up study. Journal of Affective Disorders. 158. 85–89. 17 indexed citations
18.
Furuya, Ryosuke, et al.. (2008). A Case of Relapse into Deep Coma Following Repeated Doses of Activated Charcoal Administered in Response to an Overdose of Vegetamin B (A Combination of Phenobarbital, Chlorpromazine, and Promethazine). Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine. 19(2). 106–112. 2 indexed citations
19.
20.
Itoh, Kei, Gakuji Ohshio, Naoki Kojima, et al.. (1999). Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT.. American Journal of Roentgenology. 173(2). 375–380. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James X. Wu Breakdown of academic impact, for papers by Andy Lee Breakdown of academic impact, for papers by Zeyad T. Sahli Breakdown of academic impact, for papers by Kristian Vinter Juul Breakdown of academic impact, for papers by Christoph Reichetzeder Breakdown of academic impact, for papers by Ho‐Cheol Kang Breakdown of academic impact, for papers by Jiuhong Yuan Breakdown of academic impact, for papers by Kiwon Kim Breakdown of academic impact, for papers by Alan O. Malabanan Breakdown of academic impact, for papers by Riccardo Pofi
Rankless by CCL
2026